EVEROLIMUS
Formula & Concentration
EVEROLIMUS – everolimus (antineoplastic) 10 mg tablet
Manufacturer
Biocon Biologics Inc.*
*Supplied through partnership with Capital Wholesale Co.
Indications
Nonfunctional neuroendocrine tumor of GI origin; nonfunctional neuroendocrine tumor of lung origin; ER(+), HER2(-) postmenopausal advanced breast cancer; SEGA associated with tuberous sclerosis; renal angiomyolipoma with tuberous sclerosis complex; metastatic renal cell carcinoma; pancreatic neuroendocrine tumor
Shelf Life and Storage
Controlled Room Temp (20-25°C)




